These were the biggest clinical trial operations deals in the three months to August 2021 clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.
HK->Shanghai Connect daily quota used 3.2%, Shanghai->HK daily quota used 2.6% FTSE China A50 -0.3%
SHANGHAI, July 6(Reuters) - China stocks dropped on Tuesday, with the blue-chip index hitting a near two-month low, as healthcare firms tumbled on worries over lofty valuations. The CSI300 index fell 0.6% to 5,055.65 at the end of the morning session, while the Shanghai Composite Index lost 0.5% to 3,515.64. Falling the most, the CSI300 healthcare index slumped 5.1%, on track for its worst day since March 8. Hangzhou Tigermed Consulting Co Ltd dropped 14.2%, while Shanghai Fosun Pharmaceutical Group Co Ltd , Aier Eye Hospital Group Co Ltd, Beijing Tongrentang Co Ltd and Wuxi AppTec Co Ltd retreated between 7.2% and 10%.
China stocks end lower as healthcare, tech firms tumble reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
RepliCel Launches Preparations for Second Skin Rejuvenation and Tendon Regeneration Clinical Studies
ACCESSWIRE
19 May 2021, 20:05 GMT+10
Clinical Research Organization, Accerise Inc., Has Been Retained To Work With RepliCel and Its Other Service Providers To Prepare Study Documentation, Plans, and Approvals for Clinical Evaluation by Multiple Clinical Sites in Japan
VANCOUVER, BC / ACCESSWIRE / May 19, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that it has retained leading clinical research organization, Accerise Inc, with offices in Tokyo and Osaka, to lead the planning and preparations for clinical research studies of RepliCel s skin rejuvenation (RCS-01) and tendon regeneration (RCT-01) cell therapy products in Japan.
RepliCel Launches Preparations for Second Skin Rejuvenation and Tendon Regeneration Clinical Studies tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.